Neuland Laboratories, Wockhardt, Suven Life Sciences, Unichem Laboratories and Indoco Remedies have rallied between 3%-17% on the BSE. At 12:39 PM, the S&P BSE Sensex was down 0.76% at 25,523 points.
Wockhardt has moved higher by 9% to Rs 1,323, extending its previous 2% gain on the BSE, after drug maker said it has received approval for Memantine hydrochloride tablets from United States Food and Drug Administration (USFDA).
Suven Life Sciences rallied 7% to Rs 221 after the company secured five product patents in China, Israel, Mexico, Singapore and Sri Lanka ) corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases.
Neuland Laboratories has soared 17% to Rs 716, also its lifetime high on the BSE. The stock of pharmaceutical firm rallied 39% from Rs 506 on August 13, post June quarter results. The S&P BSE Sensex was down 7.4% during the same period.
The company had reported more than doubled standalone net profit at Rs 7.3 crore for the quarter ended June 30, 2015 (Q1FY16), on the back of strong operational performance. It had a profit of Rs 3 crore in the same quarter a year ago.
Earnings before interest, tax, depreciation and amortization (EBITDA) margins improved 360 basis points Y-o-Y to 17.6% in Q1FY16 as against 14.0% in Q1FY15.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)